|
|
| |
| February
14;
39 (994) : 13-16 |
| Safety
of Calcium-Channel Blockers; |
| More
New Drugs for HIV and Associated Infections |
| February
28; 39 (995) : 17-20 |
| Reteplase
(Retavase); |
| Zileuton
for Asthma; |
| Adapalene
for Acne |
| |
|
|
|
|
| |
| May
9;
39 (1000) : 45-48 |
| Azelastine
Nasal Spray for Allergic Rhinitis; |
Treatment
of Lyme Disease
(Superseded
by issue 1209 - 5/23/2005) |
| May
23; 39 (1001) : 49-52 |
| Troglitazone
for Non-Insulin-Dependent Diabetes Mellitus; |
| Topiramate
for Epilepsy |
| |
|
| |
| June
6;
39 (1002) : 53-56 |
| Donepezil
(Aricept) for Alzheimer's Disease; |
| Brimonidine
- An Alpha2-Agonist for Glaucoma; |
| Pentosan
for Interstitial Cystitis |
| June
20; 39 (1003) : 57-60 |
| Topical
Penciclovir for Herpes Labialis; |
| Cabergoline
for Hyperprolactinemia; |
| Midodrine
for Orthostatic Hypotension |
| |
|
| |
| July
4;
39 (1004) : 61-64 |
| Glatiramer
Acetate for Relapsing Multiple Sclerosis; |
| Tizanidine
for Spasticity; |
| Topical
Butenafine for Tinea Pedis |
| July
18; 39 (1005) : 65-68 |
| Tiludronate
for Paget's Disease of Bone; |
| Fosfomycin
for Urinary Tract Infections |
| |
|
|
|
|
|
| |
| November
7;
39 (1013) : 103-106 |
| Mibefradil--A
New Calcium-Channel Blocker; |
| Two
New Retinoids for Psoriasis |
| November
21; 39 (1014) : 107-110 |
| St.
John's Wort; |
| Olopatadine
for Allergic Conjunctivitis; |
| Pramipexole
and Ropinirole for Parkinson's Disease |
| |
|
|
